187 related articles for article (PubMed ID: 26999717)
1. Kaiso depletion attenuates transforming growth factor-β signaling and metastatic activity of triple-negative breast cancer cells.
Bassey-Archibong BI; Kwiecien JM; Milosavljevic SB; Hallett RM; Rayner LG; Erb MJ; Crawford-Brown CJ; Stephenson KB; Bédard PA; Hassell JA; Daniel JM
Oncogenesis; 2016 Mar; 5(3):e208. PubMed ID: 26999717
[TBL] [Abstract][Full Text] [Related]
2. Kaiso depletion attenuates the growth and survival of triple negative breast cancer cells.
Bassey-Archibong BI; Rayner LG; Hercules SM; Aarts CW; Dvorkin-Gheva A; Bramson JL; Hassell JA; Daniel JM
Cell Death Dis; 2017 Mar; 8(3):e2689. PubMed ID: 28333150
[TBL] [Abstract][Full Text] [Related]
3. Loss of Kaiso expression in breast cancer cells prevents intra-vascular invasion in the lung and secondary metastasis.
Kwiecien JM; Bassey-Archibong BI; Dabrowski W; Rayner LG; Lucas AR; Daniel JM
PLoS One; 2017; 12(9):e0183883. PubMed ID: 28880889
[TBL] [Abstract][Full Text] [Related]
4. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
[TBL] [Abstract][Full Text] [Related]
5. Dancing from bottoms up - Roles of the POZ-ZF transcription factor Kaiso in Cancer.
Pierre CC; Hercules SM; Yates C; Daniel JM
Biochim Biophys Acta Rev Cancer; 2019 Jan; 1871(1):64-74. PubMed ID: 30419310
[TBL] [Abstract][Full Text] [Related]
6. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.
Di L; Liu LJ; Yan YM; Fu R; Li Y; Xu Y; Cheng YX; Wu ZQ
J Exp Clin Cancer Res; 2019 Mar; 38(1):134. PubMed ID: 30898152
[TBL] [Abstract][Full Text] [Related]
8. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
[TBL] [Abstract][Full Text] [Related]
9. Elevated TGF-β1 and -β2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells.
Kim S; Lee J; Jeon M; Nam SJ; Lee JE
Cytokine; 2015 Sep; 75(1):151-8. PubMed ID: 26088755
[TBL] [Abstract][Full Text] [Related]
10. Identification of a PEAK1/ZEB1 signaling axis during TGFβ/fibronectin-induced EMT in breast cancer.
Agajanian M; Runa F; Kelber JA
Biochem Biophys Res Commun; 2015 Sep; 465(3):606-12. PubMed ID: 26297948
[TBL] [Abstract][Full Text] [Related]
11. Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype.
Karihtala P; Auvinen P; Kauppila S; Haapasaari KM; Jukkola-Vuorinen A; Soini Y
Breast Cancer Res Treat; 2013 Feb; 138(1):81-90. PubMed ID: 23412770
[TBL] [Abstract][Full Text] [Related]
12. MAGE-A is frequently expressed in triple negative breast cancer and associated with epithelial-mesenchymal transition.
Wang H; Sang M; Geng C; Liu F; Gu L; Shan B
Neoplasma; 2016; 63(1):44-56. PubMed ID: 26639233
[TBL] [Abstract][Full Text] [Related]
13. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
[TBL] [Abstract][Full Text] [Related]
14. Fisetin Inhibited Growth and Metastasis of Triple-Negative Breast Cancer by Reversing Epithelial-to-Mesenchymal Transition via PTEN/Akt/GSK3β Signal Pathway.
Li J; Gong X; Jiang R; Lin D; Zhou T; Zhang A; Li H; Zhang X; Wan J; Kuang G; Li H
Front Pharmacol; 2018; 9():772. PubMed ID: 30108501
[TBL] [Abstract][Full Text] [Related]
15. FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells.
Taliaferro-Smith L; Oberlick E; Liu T; McGlothen T; Alcaide T; Tobin R; Donnelly S; Commander R; Kline E; Nagaraju GP; Havel L; Marcus A; Nahta R; O'Regan R
Oncotarget; 2015 Mar; 6(7):4757-72. PubMed ID: 25749031
[TBL] [Abstract][Full Text] [Related]
16. Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity.
Ferrari-Amorotti G; Chiodoni C; Shen F; Cattelani S; Soliera AR; Manzotti G; Grisendi G; Dominici M; Rivasi F; Colombo MP; Fatatis A; Calabretta B
Neoplasia; 2014 Dec; 16(12):1047-58. PubMed ID: 25499218
[TBL] [Abstract][Full Text] [Related]
17. Kaiso Protein Expression Correlates with Overall Survival in TNBC Patients.
Bocian A; Kędzierawski P; Kopczyński J; Wabik O; Wawruszak A; Kiełbus M; Miziak P; Stepulak A
J Clin Med; 2023 Jan; 12(1):. PubMed ID: 36615173
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of non-histone molecule miR205 and LRG1 post-transcriptional de-regulation by SETD1A in triple negative breast cancer.
Mohamad Hanif EA
Mol Biol Rep; 2019 Dec; 46(6):6617-6624. PubMed ID: 31552595
[TBL] [Abstract][Full Text] [Related]
19. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition of Histone Deacetylases Reverses Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through a Slug Mediated Mechanism].
Rahimian A; Barati G; Mehrandish R; Mellati AA
Mol Biol (Mosk); 2018; 52(3):474-481. PubMed ID: 29989579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
